Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells

被引：0
|
作者：
Atefeh Sharifhoseini
Masoud Heshmati
Amin Soltani
Mahshad Entezam
Hedayatollah Shirzad
Morteza Sedehi
Babri A. Judd
Mohammad-Saeid Jami
Mahdi Ghatrehsamani
机构：
[1] Shahrekord University of Medical Sciences,Cellular and Molecular Research Center
[2] Shahrekord University of Medical Sciences,Department of Microbiology and Immunology
[3] Shahrekord University of Medical Sciences,Department of Epidemiology and Biostatistics, School of Health
[4] Immunology Science Editors,Department of Neurology, David Geffen School of Medicine
[5] University of California Los Angeles (UCLA),undefined
来源：
Molecular Biology Reports | 2023年 / 50卷
关键词：
Breast cancer; BET inhibitor; JQ1; IL-6; Breast cancer stem cell; CXCR4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8319 / 8328
页数：9
相关论文
共 50 条
  • [21] Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins
    Lai, Jiacheng
    Liu, Ziqiang
    Zhao, Yulei
    Ma, Chengyuan
    Huang, Haiyan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
    Yamamoto, Keisuke
    Tateishi, Keisuke
    Kudo, Yotaro
    Hoshikawa, Mayumi
    Tanaka, Mariko
    Nakatsuka, Takuma
    Fujiwara, Hiroaki
    Miyabayashi, Koji
    Takahashi, Ryota
    Tanaka, Yasuo
    Ijichi, Hideaki
    Nakai, Yousuke
    Isayama, Hiroyuki
    Morishita, Yasuyuki
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Fukayama, Masashi
    Koike, Kazuhiko
    ONCOTARGET, 2016, 7 (38) : 61469 - 61484
  • [23] Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
    Fu, Rong
    Zu, Shi-Jia
    Liu, Yan-Jun
    Li, Jia-Cheng
    Dang, Wen-Zhen
    Liao, Li-Ping
    Liu, Li-Ping
    Chen, Pan-Yu
    Huang, He-Ming
    Wu, Kang-Hui
    Zhou, Bing
    Pan, Qin
    Luo, Cheng
    Zhang, Yuan-Yuan
    Li, Guang-Ming
    BIOENGINEERED, 2022, 13 (04) : 10914 - 10930
  • [24] Combination treatment with bromodomain and extra-terminal motif inhibitors in triple-negative breast cancer
    Schafer, Johanna M.
    Lehmann, Brian D.
    Redman, Lindsay N.
    Liu, Phillip
    Stubbs, Matthew
    Ruggeri, Bruce
    Scherle, Peggy
    Pietenpol, Jennifer A.
    CANCER RESEARCH, 2018, 78 (04)
  • [25] Therapeutic targeting of bromodomain and extra-terminal proteins degradation in triple-negative breast cancer
    Bai, Longchuan
    Zhou, Bing
    Yang, Chao-Yie
    Ji, Jiao
    McEachern, Donna
    Przybranowski, Sally
    Wang, Shaomeng
    CANCER RESEARCH, 2017, 77
  • [26] MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
    Kato, Fuyumi
    Fiorentino, Francesco Paolo
    Alibes, Andreu
    Perucho, Manuel
    Sanchez-Cespedes, Montse
    Kohno, Takashi
    Yokota, Jun
    ONCOTARGET, 2016, 7 (47) : 77378 - 77388
  • [27] Jq1, A Bromodomains And Extra-Terminal (bet) Protein Mimic, Decreases Remodelling And Inflammation In Pulmonary Vascular Cells: Implications For Pulmonary Arterial Hypertension
    Mumby, S.
    Gambaryan, N.
    Wort, J.
    Adcock, I. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] Effect of BET protein inhibitor JQ1 on colorectal cancer cells
    Takeda, Takashi
    Yokoyama, Yuhki
    Kitagawa, Kumi
    Miyoshi, Norikatsu
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishida, Naohiro
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Yamamoto, Hirofumi
    CANCER SCIENCE, 2018, 109 : 1306 - 1306
  • [29] Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
    Chan, Kwok-Ho
    Zengerle, Michael
    Testa, Andrea
    Ciulli, Alessio
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 504 - 513
  • [30] Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines
    Rahnasto-Rilla, Minna
    Puumalainen, Tatu
    Karttunen, Vilma
    Adla, Santosh Kumar
    Lahtela-Kakkonen, Maija
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 112
12345